Home › Funds › Dundas Partners LLP › RMD

Dundas Partners LLP position in RMD

RESMED INC · Health Care

Dundas Partners LLP reported holding 203,021 shares of RMD (RESMED INC) in its Q3 2026 13F filing — a position valued at US$44.9M, representing 3.56% of its reported portfolio and ranking #11 among its reported holdings. Dundas Partners LLP has disclosed RMD holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)203.02K sh
Reported value held$44.89M
Portfolio Weight3.56%
First reportedQ1 2024
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Dundas Partners LLP's RMD position evolved

Dundas Partners LLP first disclosed a stake in RMD in Q1 2024 at 108,868 shares (US$21.6M). The position peaked in Q4 2025 at 204,962 shares, worth US$49.4M. Across 11 filings, Dundas Partners LLP increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 203,021 shares valued at US$44.9M.

Quarter by quarter

QuarterSharesValueChange
Q1 2024 108.87K $21.56M New
Q2 2024 132.69K $25.40M Add
Q3 2024 140.56K $34.31M Add
Q4 2024 140.56K $32.15M Hold
Q1 2025 152.18K $34.07M Add
Q2 2025 152.18K $39.26M Hold
Q3 2025 175.12K $47.93M Add
Q4 2025 204.96K $49.37M Add
Q1 2026 203.02K $45.57M Reduce
Q2 2026 203.02K $39.56M Hold
Q3 2026 203.02K $44.89M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RMD and 13F data

RMD (RESMED INC) is a Health Care company. 31 other funds we track also report a position in RMD — the largest reported positions include Ilex Capital Partners (UK) LLP (US$163.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RMD

All RMD fund holders →

FAQ

How long has Dundas Partners LLP held RMD?

Dundas Partners LLP has disclosed RMD holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Dundas Partners LLP's current position in RMD?

As of Q3 2026, Dundas Partners LLP holds 203.02K shares of RMD (RESMED INC), valued at $44.89M, representing 3.56% of its reported portfolio and ranking #11.

Has Dundas Partners LLP been buying or selling RMD?

In the latest 13F filing (Q3 2026), Dundas Partners LLP held unchanged its position in RMD. The position peaked in Q4 2025 at 204.96K shares.

Which other funds hold RMD?

Other major institutional holders of RMD include Ilex Capital Partners (UK) LLP, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.